Search results
Results from the WOW.Com Content Network
Use appears to be safe during pregnancy. [9] [3] It is classified as an osmotic laxative: [4] It works by increasing the amount of water in the stool. [5] Macrogol came into use as a bowel prep in 1980 and was approved for medical use in the United States in 1999. [10] [11] [12] It is available as a generic medication and over the counter.
However, not all of them are safe to use during pregnancy. One of the components of bismuth subsalicylate is salicylate, which is a component that crosses the placenta. Due to this, there is an increased risk for intrauterine growth retardation, fetal hemorrhage, and maternal hemorrhage within organogenesis and in the second/third trimester. [ 12 ]
Docusate is the common chemical and pharmaceutical name of the anion bis(2-ethylhexyl) sulfosuccinate, also commonly called dioctyl sulfosuccinate (DOSS). [2] [3] [4]Salts of this anion, especially docusate sodium, are widely used in medicine as laxatives and as stool softeners, by mouth or rectally. [1]
Because of the lack of research on Botox use during pregnancy, the FDA has classified it as a category C drug, “meaning there is little research to determine if it is safe during pregnancy ...
WASHINGTON (Reuters) -President-elect Donald Trump said on Saturday the U.S. should not be involved in the conflict in Syria, where rebel forces are threatening the government of President Bashar ...
The breasts change during pregnancy to prepare for lactation, and more changes occur immediately after the birth. Progesterone is the hormone that influences the growth of breast tissue before the birth. Afterwards, the endocrine system shifts from producing hormones that prevent lactation to ones that trigger milk production. [3]
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Good sleep is crucial for your overall health, but new research suggests it could impact your ...
This is an important time for prevention, as acquiring HIV during pregnancy increases the risk of transmission to the infant. [6] Global oral PrEP accessibility for women, including those who are either pregnant or breastfeeding, is limited. In addition, there is minimal research on the effects of injectable PrEP and pregnancy outcomes. [21]